Behind the Luck.
Release time:
2020-08-14
"Luck"
Artificial Bezoar Workshop Reconstruction Documentary
After four months of intense work, 8# September 9 , the artificial bezoar technical renovation project of Qiubin Factory was successfully completed, 8 18 , 19 , 20 , the trial production of the first three batches of products was successfully completed. Yi Shengrong, director of the Akihama Factory, lamented, "We are lucky this time".
Good luck, this is of course a joke. To do such a big project well, luck alone is of course not enough. What really plays a decisive role is the seriousness and hard work of the project team members.
Pharmaceutical Company has many years of successful experience in producing artificial bezoar, but from the beginning of the project transformation, due to the use of raw materials, production process, process standards, and production scale are almost different, so the previous experience is not for them. Help, can only be explored from scratch through the efforts of participating construction personnel. From the beginning of the
project, the project team was formed by Yi Shengrong, director of Qiubin Factory, Yu Chengfeng, production technology department, Yan Xixia, workshop director, Fang Weiming, mechanic, and Tang Songnian, electrician. While ensuring normal production, the project began to transform. The civil engineering project of workshop
started in March 4 . The project team members divided their work according to their own fields. Fang Weiming and Tang Songnian, who were responsible for equipment selection, went to many equipment manufacturers to understand relevant information, make comparisons and prepare for bidding. Compared with the previous production, the requirements for environmental protection are higher now. When designing the artificial bezoar workshop, it was decided to adopt dust-free transportation. All equipment is connected through pipelines. In order to meet this requirement, most equipment must be customized from the manufacturer. Before the formal bidding of the equipment, the project team also held a special meeting to brainstorm and put forward opinions and suggestions on equipment selection according to the collected information and their own work experience. It has been suggested that corn starch is one of the main raw materials for the production of artificial bezoar. A lot of heat will be generated during the ball milling process. If the temperature is too high, the starch will stick together and affect the quality of the product. Although there is no requirement for this in the process standard, it can be related to the quality of the product, so when selecting the equipment, the equipment manufacturer is required to increase the cooling system for the heat dissipation problem of the ball mill. Fang Weiming said that it takes three months for general equipment manufacturers to obtain orders and provide products, but we only have more than one month, and the equipment is not stereotyped, so the two sides have communicated repeatedly many times.
Despite this, there were still some small "episodes" in the acceptance stage before the equipment entered the site ". There is a gap between the inlet and outlet of the equipment and the previous requirements, which will cause waste of raw materials. But because the construction period is very tight, the time nodes of each link are very close, if you can not enter the site on time, the whole project will be affected. This can be anxious for the project team. After communication and arrangement, it was finally decided to give the equipment manufacturer a week to revise it. After meeting the required requirements, the equipment was pulled over quickly. Other minor problems can only be to let the equipment manufacturer personnel come over and make on-site modifications.
In the trial production stage, in order to save costs, Qiubin Factory decided that the batch of products is 100 kg, while the design capacity of the equipment is 500 kg. There is no data that can be directly referred to for the process parameters such as ball mill speed, ball milling time and ball quantity. Before the trial, the members of the project team also consulted relevant production enterprises, however, the other party has only tried batch 300 kg, and has not succeeded. There are more than ten kinds of trial production schemes involved in the three parameters. Time and cost are not allowed to try multiple schemes. We can only rely on the collection and selection of indirect experience collected by project team members from various channels, and finally confirm the formation of the scheme decided to put into production. The trial production was an unexpected success. All the indexes of the three batches of trial production products passed the test. Moreover, the color, the most difficult index to control for artificial bezoar, was highly recognized by the sales agent.
The implementation of the whole project is relatively smooth, and there may be elements of luck, but behind this "luck", only the participants know how much effort and hardship they have put in. Cleaning the workshop equipment happens to be the hottest time. The weather has been more than 40 degrees for more than half a month, which makes the project team members unable to bear it. The workshop that has just been renovated is very dusty, but in order to ensure the cleaning quality, the air conditioner cannot be turned on, so it can only be cleaned under high temperature. Once out of the workshop, the whole person seems to have been soaked in water, and none of his body is dry. Moreover, his body is covered with dust. If there is something to do in the production workshop, he has to change clothes first.
Yan Xixia was impressed by one thing. The proportion and amount of balls in the ball mill will directly affect the product quality. For this reason, the two employees put 4 alumina balls of different sizes, totaling 2 tons, into small baskets one by one, and poured them into the ball mill with their bare hands for testing. The ball mill is large in size, and the feed port is above the machine. Employees holding the ball have to walk on a platform more than two meters high before they can pour in. If the ratio is not right, it has to be poured out again, cleaned, dried, and then poured in baskets again. This data alone has been tried for 3. four days. It goes up and down dozens of times a day. It is completely a physical job. Sometimes my hands shake after work. And sometimes afraid of miscounting the number of balls, employees squat down directly one by one.
Not only that, during the entire construction period from 4 to 7 February, Yu Chengfeng, Fang Weiming and Tang Songnian did not rest for a day and gave up their holidays. As long as the construction unit was present, they would have to be there. Finally, even the number of overtime days was not counted.
The end of the three batches of trial production products does not mean the end of this technological transformation project. They have a more important task, that is, to apply for GMP certification, and are now preparing for relevant materials. (Reporter Ni Yingzhen)
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31